The number of FDA approved implantable hearing devices (IHD) available has increased in the last two decades. In addition, the indications for common IHD such as cochlear implants continue to evolve and expand over time. As such, understanding the spectrum of IHD options and their respective indications can be challenging to otolaryngologists and neurotologists alike. Given recent findings of the connection between cognitive decline, hearing loss and hearing rehabilitation it is critical that providers seeing patients with hearing loss have a strong working knowledge of all aspects of hearing aids and IHD so that they can optimally counsel and treat patients. In this presentation (Part I) our panel of experienced neurotologists will review the IHD options currently available in the United States and discuss in detail the INDICATIONS for each including cochlear implants, bone conducting hearing aids and implantable middle ear devices amongst others. Details regarding the SURGICAL PROCEDURES, COMPLICATIONS, AND INSURANCE CONSIDERATIONS will be reviewed to provide a complete framework for attendees to draw upon when counseling patients. This panel assumes little prior understanding of IHD and will be tailored to a broad audience encompassing trainees, advanced practice providers, practicing otolaryngologists and neurotologists. Our panel was very well received in its first two years of presentation, and we look forward to the opportunity to present it once again now having incorporated feedback from the last two years sessions and expanded the breadth and depth of the topics covered by our panel of experts.